Trial Profile
Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer Patients: An Open-label, Single-arm, Multicenter Phase II Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Nov 2021
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Raltitrexed
- Indications Colorectal cancer
- Focus Therapeutic Use
- 04 Jun 2019 Safety and efficacy results published in conjunction with 55th Annual Meeting of the American Society of Clinical Oncology (2019).
- 17 Feb 2017 New trial record